These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 597471)

  • 1. Detection of sensitized human blood lymphocytes by agglutination with basic peptides: a possible test for malignant disease.
    Bauer HW; Ax W
    Br J Cancer; 1977 Dec; 36(6):708-12. PubMed ID: 597471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAL-test for malignant disease.
    Bauer HW; Ax W
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1978 Aug; 92(1):35-40. PubMed ID: 151403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the PAL test in the diagnosis of lung cancer.
    Kłosińska-Kita E; Wiatr E; Rykiel B; Rowińska E; Roszkowski W
    J Cancer Res Clin Oncol; 1982; 103(3):287-92. PubMed ID: 7118991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of malignant processes of the colon and rectum using a new method for the demonstration of sensitized lymphocytes (PAL-test)].
    Bauer HW; Richter H; Schottler S; Ax W
    Chir Forum Exp Klin Forsch; 1978; (1978):215-9. PubMed ID: 752589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PAL test for malignant disease in man.
    Schottler WA; Bauer HW
    Br J Cancer; 1978 Feb; 37(2):319-21. PubMed ID: 629866
    [No Abstract]   [Full Text] [Related]  

  • 6. Agglutination of peripheral blood lymphocytes from cancer patients and not from healthy controls, with the F2A1 histone fraction.
    Sabolović D; Sabolović N; Moutte A; Leibovici S; Sauvezie B; Chollet P; Plagne R
    Br J Cancer; 1975 Jul; 32(1):28-33. PubMed ID: 1058037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic parameters in patients with malignant melanoma].
    Koníková E; Babusíková O; Havránková M
    Bratisl Lek Listy; 1989 Dec; 90(12):885-94. PubMed ID: 2627650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface charge characteristics of peripheral blood lymphocytes in chronic lymphatic leukemia and malignant lymphoma.
    Marikovsky Y; Resnitzky P; Reichman N
    J Natl Cancer Inst; 1978 Apr; 60(4):741-8. PubMed ID: 633385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte agglutination blocking test. A pilot study of a new simple in vitro blood test for demonstration of cancer and tissue destruction].
    Kast RE; Bjerrum OW
    Ugeskr Laeger; 1978 Oct; 140(42):2572-5. PubMed ID: 695107
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new method for the detection of sensitized lymphocytes in malignant diseases--PAL test].
    Bauer HW; Ax W
    Verh Dtsch Ges Inn Med; 1978; (84):1320-3. PubMed ID: 741956
    [No Abstract]   [Full Text] [Related]  

  • 11. Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: a comparison between protamine, poly-L-lysine and poly-L-arginine.
    Westergren I; Johansson BB
    Acta Physiol Scand; 1993 Sep; 149(1):99-104. PubMed ID: 8237428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of polypeptide molecular and side chain lengths and of side chain steric location on the kinetics of basic polypeptide-induced sensitization of primate cells to transfection.
    Dubes GR; Wegrzyn RJ
    Acta Virol; 1977 Jan; 21(1):15-24. PubMed ID: 15433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour specificity of the SCM test for cancer diagnosis.
    Chaitchik S; Asher O; Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of poly-L-lysine, poly-L-glycine and poly-L-glutamic acid on ANS fluorescence and electrokinetic potential of splenic lymphocytes in the mouse].
    Vaillier J; Vaillier D; Lematre J
    Rev Can Biol Exp; 1983 Jul; 42(2):151-62. PubMed ID: 6196811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differently.
    Symonds P; Murray JC; Hunter AC; Debska G; Szewczyk A; Moghimi SM
    FEBS Lett; 2005 Nov; 579(27):6191-8. PubMed ID: 16243317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of responsiveness to hapten conjugates of poly-L-lysine and of a copolymer of L-glutamic acid and L-lysine to lethally irradiated nonresponder guinea pigs by bone marrow or lymph node and spleen cells from responder guinea pigs.
    Foerster J; Green I; Lamelin JP; Benacerraf B
    J Exp Med; 1969 Nov; 130(5):1107-22. PubMed ID: 4899853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of arginine-glycine-aspartic peptides conjugated poly(lactic acid-co-L-lysine) diblock copolymer.
    Yu H; Guo X; Qi X; Liu P; Shen X; Duan Y
    J Mater Sci Mater Med; 2008 Mar; 19(3):1275-81. PubMed ID: 17705054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mucin release from airway goblet cells by polycationic peptides.
    Ko KH; Lee CJ; Shin CY; Jo M; Kim KC
    Am J Physiol; 1999 Oct; 277(4):L811-5. PubMed ID: 10516223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the bactericidal activity of epsilon-poly-l-lysine to the storage of human platelet concentrates.
    Tanaka S; Hayashi T; Tateyama H; Matsumura K; Hyon SH; Hirayama F
    Transfusion; 2010 Apr; 50(4):932-40. PubMed ID: 19951313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physicochemical study of platelet aggregation by 3 polylysines].
    Stoltz JF; Streiff F; Nicolas A; Alexandre P; Larcan A
    C R Seances Soc Biol Fil; 1975; 169(6):1424-8. PubMed ID: 132231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.